IRON NASDAQ
Disc Medicine, Inc.
1W: -1.1%
1M: -19.4%
3M: -16.2%
YTD: -18.4%
1Y: -3.8%
3Y: +33.1%
5Y: +48.3%
$64.51
+0.90 (+1.41%)
Weekly Expected Move ±4.4%
$59
$62
$65
$67
$70
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
19 relationships19
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2022-08-10
Earliest Filing
2025-10-22
Latest Filing
partner: 17
investor: 1
target: 1
Counterparties (Filed by IRON)
19 relationshipsCompanies named in IRON's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Jefferies LLC | JEF | partner | Underwriter for the common stock offering | 2025-10-22 | View |
| Leerink Partners LLC | — | partner | Underwriter for the common stock offering | 2025-10-22 | View |
| Morgan Stanley & Co. LLC | MS-PL | partner | Underwriter for the common stock offering | 2025-10-22 | View |
| Cantor Fitzgerald & Co. | — | partner | Underwriter for the common stock offering | 2025-10-22 | View |
| AI DMI LLC | — | investor | Selling stockholder participating in the offering | 2025-10-22 | View |
| Jefferies LLC | JEF | partner | Underwriter for the common stock offering | 2025-01-24 | View |
| Leerink Partners LLC | — | partner | Underwriter for the common stock offering | 2025-01-24 | View |
| Stifel, Nicolaus & Company, Incorporated | — | partner | Underwriter for the common stock offering | 2025-01-24 | View |
| Cantor Fitzgerald & Co. | — | partner | Underwriter for the common stock offering | 2025-01-24 | View |
| Cantor Fitzgerald & Co. | — | partner | Entered into a Controlled Equity Offering Sales Agreement to act as sales agent for the Company's common stock. | 2024-11-15 | View |
| Jefferies LLC | JEF | partner | Prior sales agent whose Open Market Sale Agreement was terminated by the Company. | 2024-11-15 | View |
| Jefferies LLC | JEF | partner | Entered into an Open Market Sale Agreement to act as sales agent and principal for the sale of Disc Medicine, Inc. commo | 2023-12-05 | View |
| Jefferies LLC | JEF | partner | Sales agent and principal for open market sale of common stock | 2023-10-10 | View |
| Morgan Stanley & Co. LLC | MS-PL | partner | Underwriter for the public offering of common stock and pre-funded warrants | 2023-06-16 | View |
| Stifel, Nicolaus & Company, Incorporated | — | partner | Underwriter for the public offering of common stock and pre-funded warrants | 2023-06-16 | View |
| BMO Capital Markets Corp. | — | partner | Underwriter for the public offering of common stock and pre-funded warrants | 2023-06-16 | View |
| Mabwell Therapeutics, Inc. | — | partner | Entered into an exclusive license agreement with Disc Medicine, Inc. for antibody products | 2023-01-23 | View |
| Mabwell (Shanghai) Bioscience Co., Ltd | — | partner | Parent company of Mabwell Therapeutics, Inc. | 2023-01-23 | View |
| Disc Medicine, Inc. | IRON | target | Target company in the merger agreement with Gemini Therapeutics, Inc. | 2022-08-10 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-10 | Regulation FD; Other Events; Exhibits | View | |
| 2026-07-30 | Earnings Release; Exhibits | View | |
| 2026-06-30 | Material Agreement; Financial Obligation | Agreement | View |
| 2026-06-24 | Shareholder Vote | View | |
| 2026-05-05 | Earnings Release; Exhibits | View | |
| 2026-02-27 | Costs Associated with Exit or Disposal Activities | View | |
| 2026-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-17 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-02-13 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-12-08 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-22 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-10-20 | Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Sta | View | |
| 2025-10-17 | Other Events | View | |
| 2025-10-06 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-14 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-06-13 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR